apollo

Select Address

Search Medicines
  • Login
  1. Home
  2. Inflitza 25 Softgel Capsule

  3. Inflitza 25 Softgel Capsule Substitute

Inflitza 25 Softgel Capsule Substitute

Medicine Composition:

MIDOSTAURIN-25MG

All Substitutes & Brand Comparisons

call Doctor

When Should You Consider Switching from Inflitza 25 Softgel Capsule?

Patients may explore substitutes in the following scenarios:

  • High monthly cost of Inflitza 25 Softgel Capsule
  • Non-availability in local pharmacies
  • Generic recommendation by a doctor
  • Side effects or better tolerability with alternatives

What to Know Before Switching

Before you switch from Inflitza 25 Softgel Capsule to another medicine, here are some important points to keep in mind:

bannner image

Same salt, different brands:

Most substitutes contain the same active ingredient - MIDOSTAURIN-25MG, but the fillers, coating, or manufacturing quality may vary slightly.

bannner image

Consult your doctor first:

Even if the salt is the same, your doctor can confirm if the substitute is right for your condition, dosage, and health history.

bannner image

Watch out for allergies or reactions:

Some people may react differently to certain brands due to inactive ingredients. If you notice any side effects, inform your doctor immediately.

bannner image

Price ≠ effectiveness:

A lower-priced substitute doesn't mean it's less effective. Many generic medicines work just as well as branded ones.

bannner image

Check the dosage form and strength:

Always match the substitute’s strength (e.g., 5mg, 10mg) and form (tablet, capsule, syrup) with what your doctor prescribed.

Uses

Inflitza 25 Softgel Capsule is used in the treatment of Acute myeloid leukaemia (AML), aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated haematological neoplasm (SM-AHN), and mast cell leukaemia (MCL). The detailed uses of Inflitza 25 Softgel Capsule are as follows:

  • Treatment of FLT3-Mutated Acute Myeloid Leukemia (AML): Inflitza 25 Softgel Capsule is used in combination with standard chemotherapy (cytarabine and daunorubicin) to treat newly diagnosed AML in adults who test positive for FLT3 mutations.
  • Management of Advanced Systemic Mastocytosis (ASM): Inflitza 25 Softgel Capsule helps reduce the proliferation of abnormal mast cells in patients with aggressive systemic mastocytosis, improving symptoms and slowing disease progression.
  • Therapy for Mast Cell Leukemia (MCL) and SM-AHN: Inflitza 25 Softgel Capsule is used for rare blood disorders like mast cell leukemia and systemic mastocytosis with associated hematologic neoplasm, targeting abnormal cell growth in bone marrow and blood.
  • Tyrosine Kinase Inhibition Mechanism: Inflitza 25 Softgel Capsule works by blocking multiple kinases, including FLT3, which are involved in cancer cell growth and survival, making it effective against certain hematologic malignancies.

Medicinal Benefits

Inflitza 25 Softgel Capsule belongs to the group of medicines called protein kinase inhibitors used to treat acute myeloid leukaemia (AML) in patients who are FLT3 mutation-positive. It is also used to treat aggressive systemic mastocytosis (ASM), systemic mastocytosis with associated haematological neoplasm (SM-AHN), or mast cell leukaemia (MCL). Inflitza 25 Softgel Capsule contains Midostaurin, which works by blocking the action of kinase enzymes in abnormal cells and stops their division and growth. Thereby, it helps prevent the spread of cancer and mast cells.

FAQs

The substitutes of Inflitza 25 Softgel Capsule contain the same active salt(s) - MIDOSTAURIN-25MG. However, they may differ in price, manufacturing quality, and inactive ingredients. Speak to your doctor to find a suitable option.

Switching to a generic substitute medicine in the place of Inflitza 25 Softgel Capsule is often possible if it has the same salt, strength, and dosage form. But always check with your doctor before making any changes to your medication.

Generics versions of Inflitza 25 Softgel Capsule are typically more affordable because they don’t include the original brand's research, development, and marketing costs. They contain the same active ingredient and are approved for safety and effectiveness.

Most people don’t notice any difference. However, some may react to different fillers or coatings. If you notice any unusual symptoms after switching, consult your doctor.

Make sure the new medicine has the same active salt, strength, dosage form. Always confirm the change with your doctor or pharmacist.

Apollo 247 Floating Button

Buy best Neoplastic Disorders products by